Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion
Updated Oct. 23, 2023 6:55 am ETRoche Holding has agreed to buy the developer of a bowel-disease treatment from Roivant ...
Updated Oct. 23, 2023 6:55 am ETRoche Holding has agreed to buy the developer of a bowel-disease treatment from Roivant ...
SYDNEY—New Zealand’s financial system is well placed to handle rising interest rates and uncertainty in the international financial system, the ...
WESTBOROUGH, MASS. — In a brightly lighted warehouse tucked along an industrial road about 45 minutes west of Boston, a ...
© CFO News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 CFO News Hubb All rights reserved.